The year of weight-loss drugs
FT News Briefing
Forhecz Topher
4.4 • 1.3K Ratings
🗓️ 22 December 2023
⏱️ 15 minutes
🧾️ Download transcript
Summary
Chancellor Jeremy Hunt raised the prospect of the Bank of England reducing interest rates in 2024 in an interview with the FT, and Novo Nordisk’s drugs for obesity could have a profound effect on healthcare, society and our relationship with food. Plus, part three or our three-part series on a changing India looks at the country’s booming fertility industry.
Mentioned in this podcast:
FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk
Jeremy Hunt raises prospect of Bank of England rate cuts in 2024
Credit: Vogue.com
Credit: Jimmy Kimmel Live
The FT News Briefing is produced by Fiona Symon, Sonja Hutson, Kasia Broussalian and Marc Filippino. Additional help by Breen Turner, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Our engineer is Monica Lopez. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music.
Read a transcript of this episode on FT.com
Hosted on Acast. See acast.com/privacy for more information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | The UK's energy partner. |
| 0:06.0 | Learn more at equinore. |
| 0:10.0 | Good morning from the Financial Times. Today is Friday, December 22nd. And this is your |
| 0:17.2 | FT news briefing. The Bank of England could start cutting rates next year and weight loss drugs like |
| 0:24.3 | Ozempeck have been in the news a lot but are we missing their true potential? |
| 0:29.6 | They're not just like Slimming drabs but they're actually these really powerful preventative tools. |
| 0:35.0 | Plus we take a look at the booming fertility industry in India. |
| 0:40.0 | I'm Mark Filipino, and here's the news you need to start your day. UK Chancellor Jeremy Hunt has raised the prospect of cutting interest rates in 2024. |
| 1:01.9 | He told the FT recently that next year the country needs to throw off |
| 1:05.7 | its pessimism about the economy. Not too shocking, especially since we saw the rate of UK inflation drop to 3.9% last month and interest rates in the UK are at a 15 year high. |
| 1:20.0 | But ultimately it's up to the Bank of England. |
| 1:22.5 | And one of the bank's governor said this week |
| 1:24.7 | that uncertainty over the UK's labor market |
| 1:27.4 | would mean it needs to wait before it can cut rates. |
| 1:37.0 | The FT has chosen Lars Furegard Jorgensen as person of the year. |
| 1:41.6 | He is the CEO of Novo Nordisk. |
| 1:44.0 | Now if neither one of those names sound familiar, the company's leading drugs probably do, |
| 1:49.6 | Ozempik and Wigovi. They're game-changing treatments for obesity and were two of the most talked |
| 1:55.4 | about medications this year. Here to discuss Jorgensen and the impact of these drugs is the |
| 2:00.4 | F.T's global pharmaceutical editor, Hannah Kueschler. Hey Hannah. Hi. is the So you're right to say that he isn't going to be a household name, but I think as |
| 2:15.5 | as anpic and we have become household names, he's got a really important role |
| 2:21.6 | because these are drugs that actually have the potential really a really to reshape society. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Forhecz Topher, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Forhecz Topher and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.